Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Polyinosinic:polycytidylic acid (poly IC), a double-stranded RNA, is an effective adjuvant in vivo. IFN-lambdas (also termed IL-28/29) are potent immunomodulatory and antiviral cytokines.
We demonstrate that poly IC injection in vivo induces large amounts of IFN-lambda, which depended on hematopoietic cells and the presence of TLR3 (Toll-like receptor 3), IRF3 (IFN regulatory factor 3), IRF7, IFN-I receptor, Fms-related tyrosine kinase 3 ligand (FL), and IRF8 but not on MyD88 (myeloid differentiation factor 88), Rig-like helicases, or lymphocytes.
Upon poly IC injection in vivo, the IFN-lambda production by splenocytes segregated with cells phenotypically resembling CD8alpha(+) conventional dendritic cells (DCs [cDCs]).
In vitro experiments revealed that CD8alpha(+) cDCs were the major producers of IFN-lambda in response to poly IC, whereas both CD8alpha(+) cDCs and plasmacytoid DCs produced large amounts of IFN-lambda in response to HSV-1 or parapoxvirus.
The nature of the stimulus and the cytokine milieu determined whether CD8alpha(+) cDCs produced IFN-lambda or IL-12p70.
Human DCs expressing BDCA3 (CD141), which is considered to be the human counterpart of murine CD8alpha(+) DCs, also produced large amounts of IFN-lambda upon poly IC stimulation.
Thus, IFN-lambda production in response to poly IC is a novel function of mouse CD8alpha(+) cDCs and their human equivalents.